DNAAF10
Dynein axonemal assembly factor 10
Also known as: DAA10_HUMAN, FLJ31741, Monad, WDR92
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96MX6
- Gene
- DNAAF10
- Ensembl
- ENSG00000243667
- Chromosome
- 2
- Canonical length
- 357 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a protein with two WD40 repeat domains thought to be involved in an apoptosis via activation of caspase-3. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
357 residues, UniProt reviewed canonical sequence.
>Q96MX6|DNAAF10
1 MSAFEKPQII AHIQKGFNYT VFDCKWVPCS AKFVTMGNFA RGTGVIQLYE IQHGDLKLLR
61 EIEKAKPIKC GTFGATSLQQ RYLATGDFGG NLHIWNLEAP EMPVYSVKGH KEIINAIDGI
121 GGLGIGEGAP EIVTGSRDGT VKVWDPRQKD DPVANMEPVQ GENKRDCWTV AFGNAYNQEE
181 RVVCAGYDNG DIKLFDLRNM ALRWETNIKN GVCSLEFDRK DISMNKLVAT SLEGKFHVFD
241 MRTQHPTKGF ASVSEKAHKS TVWQVRHLPQ NRELFLTAGG AGGLHLWKYE YPIQRSKKDS
301 EGIEMGVAGS VSLLQNVTLS TQPISSLDWS PDKRGLCVCS SFDQTVRVLI VTKLNKILocalizationUniProt · AlphaFold · HPA
Whether an antibody against DNAAF10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 15 nTPM
- skeletal muscle: 11 nTPM
- fallopian tube: 10 nTPM
- skin: 10 nTPM
- lymph node: 9.1 nTPM
- choroid plexus: 8.7 nTPM
Single-cell type
- respiratory ciliated cells: 68 nCPM
- fallopian tube ciliated cells: 61 nCPM
- ependymal cells: 55 nCPM
- epididymal efferent duct ciliated cells: 46 nCPM
- adrenal medulla cells: 32 nCPM
- endometrial ciliated cells: 31 nCPM
Immune cell
- NK-cell: 6.3 nTPM
- memory B-cell: 5.3 nTPM
- naive CD8 T-cell: 5 nTPM
- plasmacytoid DC: 5 nTPM
- naive B-cell: 4.8 nTPM
- MAIT T-cell: 4.2 nTPM
Brain region
- choroid plexus: 27 nTPM
- midbrain: 21 nTPM
- cerebellum: 21 nTPM
- basal ganglia: 19 nTPM
- medulla oblongata: 18 nTPM
- spinal cord: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0.01
- DepMap mean gene effect
- -0.79
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DNAAF10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DNAAF10 as an antibody target. Whether an autoantibody or antibody against DNAAF10 could matter depends on whether native DNAAF10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DNAAF10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DNAAF10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...